Accenture (NYSE:ACN) has entered multi year alliances with OpenAI, Boston Consulting Group, Capgemini, and McKinsey to speed ...

BCG, McKinsey, Accenture, and Capgemini—to accelerate adoption of its Frontier AI agent platform, reshaping enterprise ...

The UK economy is suffering from an ever-lengthening tail of low productivity businesses, according to a new report from BCG. Between 1997 and 2023, the number of firms below the 25th productivity ...

ImmunityBio has successfully established two major international distribution partnerships within days, significantly expanding the global reach of its bladder cancer immunotherapy, ANKTIVA. These ...

ImmunityBio's stock has roughly quintupled so far in 2026 as the company continues to deliver good news for investors.

OpenAI (OPENAI) has signed multi-year partnerships with Accenture (ACN), BCG, Capgemini and McKinsey to help deploy its ...

OpenAI will partner with Accenture, BCG, Capgemini and McKinsey & Company as part of a wider enterprise AI push.

OpenAI is expanding its push into the enterprise market by teaming up with four of the world’s largest consulting firms, ...

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced full-year 2025 financial and operational highlights, including approximately $113 million in net product ...

The opening weekend of the 2026 season underscored some valuable truths for a league that yearns for domestic and global acclaim ...

ImmunityBio Inc. IBRX shares are up on Monday following the company’s announcement of significant revenue growth. • ...